You are here

Novartis

Vanda's Fanapt Falls Flat

The Street

Sat, 02/5/11 - 10:45 am

5 Breakthrough Drugs for 2011

Barron's

Thu, 02/3/11 - 10:06 am

Human Genome Sciences

Bristol-Myers Squibb

Vertex Pharmaceuticals

A Foursome Of Pharma Earnings Suggests Business Is Still Tough

Investopedia

Mon, 01/31/11 - 05:07 pm

Abbott Laboratories

Bristol-Myers Squibb

Novartis Says FDA Approves Menveo in Kids, Not Infants

Bloomberg

Mon, 01/31/11 - 11:56 am

meningococcal disease

Novartis Interested in Emerging Market Bolt-On Acquisitions.

WSJ

Sun, 01/30/11 - 12:17 pm

A Busy Week For Novartis

Yahoo/CNBC

Sat, 01/29/11 - 11:46 am

Novartis's Fourth-Quarter Net Falls on Decline in Vaccine Sales, Charges

Thu, 01/27/11 - 11:20 pm

Sales growth for Novartis but rough waters ahead

Pharma Times, UK

Thu, 01/27/11 - 08:50 am

Patients With Cancer Like Steve Jobs Gain Months From Novartis, Pfizer drugs

Bloomberg

Tue, 01/25/11 - 09:28 am

Novartis Buys U.S. Cancer Lab for $470 Million

Mon, 01/24/11 - 03:24 pm

Genie About to Come Out of Ariad's Bottle

Seeking Alpha

Mon, 01/24/11 - 11:37 am

Ariad Pharmaceuticals

Novartis Buys U.S. Cancer Lab for $470 Million

NY Times, NY

Mon, 01/24/11 - 11:31 am

First MS pill may be available soon (in the UK)

Press Assocation News

Sat, 01/22/11 - 10:18 am

multiple sclerosis

Novartis MS Pill Wins European Backing as Rival Acorda Rejected

Bloomberg

Fri, 01/21/11 - 10:11 am

multiple sclerosis

Acorda Therapeutics

Major Drugmaker Sales Growth to Slow to 1.3%, Datamonitor Says

Bloomberg

Fri, 01/21/11 - 08:00 am

Here's How King Pharmaceuticals May Be Failing You

Motley Fool

Thu, 01/20/11 - 06:35 pm

Teva Pharmaceuticals

The WHO, A Novartis Exec & A Conflict Of Interest

Pharmalot

Thu, 01/20/11 - 09:52 am

Forest Labs Has Wood To Chop

Investopedia

Wed, 01/19/11 - 11:12 am

Bids Due for Sanofi, Merck Animal Health Assets, FTD Reports

Bloomberg

Wed, 01/19/11 - 10:38 am

Boehringer Ingelheim

Biosimilars: Empty Threats?

InVivo

Tue, 01/18/11 - 11:58 am

Pages